Through strategic guidance, visionary thinking, and a relentless pursuit of excellence, our senior executives steer SPT Labtech towards achieving its mission of making a real difference to human health through solving advanced laboratory challenges.
Learn more
Board of Directors
Our Board of Directors are committed to driving the long-term success and sustainability of SPT Labtech, providing expert guidance and oversight to execute the company’s ambitious commercial strategy.
Learn more
10
SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows
Continue reading
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows
Continue reading
How Novartis Is Shaping the Future of Lab Automation Through Smart Sample Transport
Continue reading
Cambridge, UK, 21 February 2024 – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, continues its partnership with the UK Health Security Agency (UKHSA) to advance global genomics surveillance. SPT Labtech has deployed pioneering automated liquid handling technology to the Oswaldo Cruz Foundation (FIOCRUZ) in Brazil, as part of the program facilitated through the New Variant Assessment Platform (NVAP) led by UKHSA.
Two advanced liquid handling instruments known as the ‘dynamic duo’ from SPT Labtech have been installed at FIOCRUZ to facilitate high-throughput sample preparation for genomic sequencing. The ‘dynamic duo’ consists of:
This news follows the announcement in September 2023, where UKHSA provided a ‘dynamic duo’ to the Caribbean Public Health Agency (CARPHA) to track new variants and pathogens in the Caribbean region.
“SPT Labtech is proud to be a part of this essential initiative in bolstering global health security through our powerful liquid handling technology.” says Joby Jenkins, Chief Technology Officer at SPT Labtech. “By enabling genomics laboratories to streamline their operations, we’re supporting the early detection of emerging infectious diseases as well as facilitating a better understanding of pathogenic evolution.”
"The New Variant Assessment Platform (NVAP) is a powerful example of the impact we can achieve through UK–Brazil collaboration. NVAP has supported Brazil to strengthen its in-country genomic sequencing capability, through capacity training and by leveraging existing infrastructure. This has not only improved the Brazilian response to the COVID-19 pandemic, but has also provided a powerful tool for future decision-making in public health. Pandemics recognize no borders, and improved genomic surveillance and data sharing, and more resilient healthcare systems, will better prepare us all for future threats." says Rossa Commane, Science and Innovation Director for Latin America.
.png?width=550&height=400&name=dynamic-duo-banner-v4%20(1).png)
The ‘dynamic duo’ from SPT Labtech combines the non-contact reagent dispensing of dragonfly discovery (left) with the multichannel low-volume positive displacement pipetting of mosquito HV genomics (right), to facilitate high-throughput sample preparation for genomic sequencing.